FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Spinal-Cord, Totally Implanted For Pain Relief

PMA: P030017 · Supplement: S374 · Decision Dec 18, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P030017 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Stimulator, Spinal-Cord, Totally Implanted For Pain Relief
Trade Name
WaveWriter Alpha Spinal Cord Stimulator (SCS) Mixed Systems, M8 Adaptor
PMA Number
P030017
Supplement Number
S374
Device Class
FDA Class 3
Product Code
LGW
Generic Name
Stimulator, spinal-cord, totally implanted for pain relief
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
Approved
Decision Code
APPR
Decision Date
December 18, 2025
Date Received
April 2, 2024
Supplement Type
Real-Time Process
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for 1) labeling updates to the WaveWriter Alpha Spinal Cord Stimulator (SCS) MRI Safety Guidelines to allow for Bl+rms limits to be set as the primary limiting condition for RF power, 2) a labeling update to the MRI Safety Guidelines and Precision Adapter M8 Instructions for Use to add the Medtronic Specify SureScan MRI Leads to the list of leads compatible with the BSN M8 Adapter as part of the WaveWriter Alpha Spinal Cord Stimulator (SCS) Mixed Systems, and 3) the WaveWriter Alpha SCS Mixed System using the Medtronic Specify SureScan leads will be labeled as MRI scan eligible.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LGW Stimulator, Spinal-Cord, Totally Implanted For Pain Relief